New Year Offer End Date: 30th April 2024
Working principle of selective laser sintering process 2 scaled

Designing Nanoparticles for Targeted Cancer Therapy

“Precision Redefined: Unleashing Nanoparticles to Target Cancer Cells”

About Program:

The program on Designing Nanoparticles for Targeted Cancer Therapy is a comprehensive program aimed at providing researchers, scientists, and healthcare professionals with in-depth knowledge and practical skills in the field of nanoparticle-based cancer therapy. This program will explore the latest advancements, strategies, and challenges associated with designing nanoparticles for targeted drug delivery to cancer cells.

Aim: The aim of the program “Designing Nanoparticles for Targeted Cancer Therapy” is to provide participants with a comprehensive understanding of the principles, techniques, and advancements in designing nanoparticles specifically tailored for targeted cancer therapy.

Program Objectives:

  • Explore Nanoparticle Design and Engineering
  • Examine Drug Loading and Release Mechanisms
  • Characterize Nanoparticle Properties
  • Improve the Pharmacokinetics
  • Reduce the Systemic Toxicities of Chemotherapies

What you will learn?

Day 1: Principles and Designing of Targeted drug-delivery systems (TDDS) for Cancer Therapy
● Overview of nanoparticles and their applications in cancer treatment
● Role of targeted therapy in cancer treatment
● Principles of TDDS design for targeted drug delivery
● Rationale behind design and application of TDDS
● Selection of suitable materials for TDDS
● Surface modifications and functionalization for target-specific interactions

Day 2: Physicochemical characterization, Biocompatibility and Applications of TDDS for Cancer Therapy

● Physicochemical characterization of TDDS
● Efficient drug loading, drug encapsulation and controlled release
● Stability and self-life of drug molecules
● In vitro and in vivo toxicity evaluation of TDDS and drug molecules, undesirable side effects
● Release kinetics and ADME
● Animal model and clinical studies

Day 3: TDDS in the Market, Various Stages of Clinical Translation and Regulatory Aspects

● FDA and the EMA approved TDDS for cancer therapy
● Mechanism of Actions
● Case Studies
● Challenges for TTDS
● Regulatory Pathways

Q&A session and open discussion

Fee Plan

INR 1999 /- OR USD 50

Intended For : Graduates, Post Graduates, Research Scholars, Academicians, Industry Professionals of Cancer Biology, Nanomedicine, Pharmaceutical Sciences

Career Supporting Skills

Nanoparticle Design Drug Delivery Optimization Preclinical Evaluation Nanoparticle Characterization Techniques In vitro Cell Culture Techniques

Program Outcomes

  • Enhanced understanding of cancer biology, including the hallmarks of cancer and oncogenic signaling pathways.
  • Familiarity with different cancer treatment modalities, such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy.
  • Knowledge of the applications of nanotechnology in cancer therapy, particularly the advantages of nanoparticles in drug delivery, imaging, and theranostics.
  • Awareness of drug resistance mechanisms in cancer and exploration of strategies to overcome or mitigate resistance through nanoparticle-based therapies.
  • Understanding of tumor targeting strategies, including active targeting using ligands or antibodies, passive targeting via the enhanced permeability and retention (EPR) effect, and physicochemical targeting based on tumor-specific characteristics.
  • Familiarity with nanoparticle synthesis techniques and formulation strategies to engineer nanoparticles with desired properties for cancer therapy.
  • Insight into the challenges associated with drug delivery in cancer therapy and the potential of nanoparticle-based systems to enhance drug delivery to tumor sites.
  • Knowledge of the clinical translation process, including regulatory considerations, clinical trial design, and ethical aspects involved in bringing nanoparticle-based therapies to patients.